1. Home
  2. FLYW vs ADMA Comparison

FLYW vs ADMA Comparison

Compare FLYW & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flywire Corporation Voting

FLYW

Flywire Corporation Voting

N/A

Current Price

$19.75

Market Cap

2.3B

Sector

Technology

ML Signal

N/A

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

N/A

Current Price

$11.40

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FLYW
ADMA
Founded
2009
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
FLYW
ADMA
Price
$19.75
$11.40
Analyst Decision
Buy
Buy
Analyst Count
15
4
Target Price
★ $21.21
$17.00
AVG Volume (30 Days)
1.1M
★ 2.7M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 450.00
N/A
EPS
0.03
★ 0.35
Revenue
★ $623,025,000.00
$42,219,783.00
Revenue This Year
$22.12
$4.93
Revenue Next Year
$15.25
$17.59
P/E Ratio
$641.33
★ $33.37
Revenue Growth
26.59
★ 43.85
52 Week Low
$10.55
$7.21
52 Week High
$19.73
$20.46

Technical Indicators

Market Signals
Indicator
FLYW
ADMA
Relative Strength Index (RSI) 62.69 64.81
Support Level $16.95 $10.57
Resistance Level $19.73 $16.58
Average True Range (ATR) 0.63 0.37
MACD 0.07 0.05
Stochastic Oscillator 99.48 75.73

Price Performance

Historical Comparison
FLYW
ADMA

About FLYW Flywire Corporation Voting

Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements, namely a payments platform, a proprietary payment network, and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: